All Videos

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, discuss the impact of biosimilars on payers, health care systems, and patients.

Expert rheumatologist and dermatologist, Drs Roy M. Fleischmann and Joel M. Gelfand discuss unmet needs in biosimilars.

Drs Roy M. Fleischmann and Joel M. Gelfand define interchangeability status and discuss its impact on the field of dermatology and rheumatology.

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how to treat tinea versicolor.

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.

Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.

Expert acne specialists discuss the types of cleansers available on the market.

Expert dermatologists discuss the impact of nonprescription acne treatment on quality of life and function.

Drs Roy M. Fleischmann and Joel M. Gelfand explain extrapolation and how it will change the field of dermatology and rheumatology.

In this week’s Pointers with Dr Portela, the 208SkinDoc gives his skin discoloration treatment tips.

Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.

Three dermatologists discuss the case of an 18-year-old patient with AD who is exploring nonsteroidal options to manage his disease.

Peter Lio, MD, clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss the importance of the skin barrier and its importance in acne treatment.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss how adherence becomes an issue in the treatment of acne and what factors lead to lack of adherence in patients.

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, define the terms associated with biosimilars, including the interchangeable designation.

An expert rheumatologist and dermatologist discuss differences between biosimilars and generic drugs.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the 5 biggest cleansing mistakes.

Drs Noor and Bhatia have a conversation about cost and financial assistance from pharmaceutical companies.

Drs Bhatia and Lamb discuss the case of a 12-year-old child with asthma and how they would manage his disease.

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.